Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis

OBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low- and middle-income countries through a systematic review and meta-analysis. METHODS: PubMed and Embase were searched for randomized...

Full description

Bibliographic Details
Main Authors: Amitabh B Suthar, Reuben Granich, Jonathan Mermin, Annelies Van Rie
Format: Article
Language:English
Published: The World Health Organization 2012-02-01
Series:Bulletin of the World Health Organization
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012000200013&lng=en&tlng=en
_version_ 1797281856472743936
author Amitabh B Suthar
Reuben Granich
Jonathan Mermin
Annelies Van Rie
author_facet Amitabh B Suthar
Reuben Granich
Jonathan Mermin
Annelies Van Rie
author_sort Amitabh B Suthar
collection DOAJ
description OBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low- and middle-income countries through a systematic review and meta-analysis. METHODS: PubMed and Embase were searched for randomized controlled trials and prospective and retrospective cohort studies that compared mortality or morbidity in HIV-infected individuals aged > 13 years on cotrimoxazole and ART and on ART alone. The Newcastle- Ottawa Quality Assessment Scale was used to assess selection, confounding and measurement bias. Publication bias was assessed using Egger's and Begg's tests. Sensitivity analysis was performed because the I-squared statistic indicated substantial heterogeneity in study results. A random-effects model was used for meta-analysis. FINDINGS: Nine studies were included. Begg and Egger P-values for the seven that reported the effect of cotrimoxazole on mortality were 0.29 and 0.49, respectively, suggesting no publication bias. The I-squared statistic was 93.2%, indicating high heterogeneity in study results. The sensitivity analysis showed that neither the follow-up duration nor the percentage of individuals with World Health Organization stage 3 or 4 HIV disease at baseline explained the heterogeneity. The summary estimate of the effect of cotrimoxazole on the incidence rate of death was 0.42 (95% confidence interval: 0.29-0.61). Since most studies followed participants for less than 1 year, it was not possible to determine whether cotrimoxazole can be stopped safely after ART-induced immune reconstitution. CONCLUSION: Cotrimoxazole significantly increased survival in HIV-infected adults on ART. Further research is needed to determine the optimum duration of cotrimoxazole treatment in these patients.
first_indexed 2024-03-07T17:03:29Z
format Article
id doaj.art-058a9de5a2c646a897154da2d2d03ec5
institution Directory Open Access Journal
issn 0042-9686
language English
last_indexed 2024-03-07T17:03:29Z
publishDate 2012-02-01
publisher The World Health Organization
record_format Article
series Bulletin of the World Health Organization
spelling doaj.art-058a9de5a2c646a897154da2d2d03ec52024-03-03T02:56:17ZengThe World Health OrganizationBulletin of the World Health Organization0042-96862012-02-01902128138S0042-96862012000200013Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisAmitabh B Suthar0Reuben Granich1Jonathan Mermin2Annelies Van Rie3University of North CarolinaWorld Health OrganizationCenters for Disease Control and PreventionUniversity of North CarolinaOBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low- and middle-income countries through a systematic review and meta-analysis. METHODS: PubMed and Embase were searched for randomized controlled trials and prospective and retrospective cohort studies that compared mortality or morbidity in HIV-infected individuals aged > 13 years on cotrimoxazole and ART and on ART alone. The Newcastle- Ottawa Quality Assessment Scale was used to assess selection, confounding and measurement bias. Publication bias was assessed using Egger's and Begg's tests. Sensitivity analysis was performed because the I-squared statistic indicated substantial heterogeneity in study results. A random-effects model was used for meta-analysis. FINDINGS: Nine studies were included. Begg and Egger P-values for the seven that reported the effect of cotrimoxazole on mortality were 0.29 and 0.49, respectively, suggesting no publication bias. The I-squared statistic was 93.2%, indicating high heterogeneity in study results. The sensitivity analysis showed that neither the follow-up duration nor the percentage of individuals with World Health Organization stage 3 or 4 HIV disease at baseline explained the heterogeneity. The summary estimate of the effect of cotrimoxazole on the incidence rate of death was 0.42 (95% confidence interval: 0.29-0.61). Since most studies followed participants for less than 1 year, it was not possible to determine whether cotrimoxazole can be stopped safely after ART-induced immune reconstitution. CONCLUSION: Cotrimoxazole significantly increased survival in HIV-infected adults on ART. Further research is needed to determine the optimum duration of cotrimoxazole treatment in these patients.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012000200013&lng=en&tlng=en
spellingShingle Amitabh B Suthar
Reuben Granich
Jonathan Mermin
Annelies Van Rie
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
Bulletin of the World Health Organization
title Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
title_full Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
title_fullStr Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
title_full_unstemmed Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
title_short Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
title_sort effect of cotrimoxazole on mortality in hiv infected adults on antiretroviral therapy a systematic review and meta analysis
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012000200013&lng=en&tlng=en
work_keys_str_mv AT amitabhbsuthar effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis
AT reubengranich effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis
AT jonathanmermin effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis
AT anneliesvanrie effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis